Ratings Aegon Ltd. Nyse

Equities

AEG

US0076CA1045

Real-time Estimate Cboe BZX Other stock markets 09:50:36 2024-05-01 am EDT			5-day change	1st Jan Change
6.165 ^USD	-0.08%		+1.31%	+7.64%

Apr. 10	Aegon: successful placement of bond issue	CF
Apr. 10	Aegon Prices $760 Million Note for General Corporate Purposes	MT

Summary

The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

Its low valuation, with P/E ratio at 8.12 and 6.74 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
The company appears to be poorly valued given its net asset value.
The company is one of the best yield companies with high dividend expectations.
For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
Over the past twelve months, analysts' opinions have been strongly revised upwards.

Weaknesses

According to forecast, a sluggish sales growth is expected for the next fiscal years.
The company's earnings growth outlook lacks momentum and is a weakness.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Sector: Life & Health Insurance

	1st Jan change	Capi.	ESG Refinitiv
AEGON LTD.	+7.64%	10.97B	-
AXA	+10.00%	76.32B	B-
METLIFE, INC.	+8.16%	50.69B	B+
AFLAC INCORPORATED	+2.33%	48.13B	B
MANULIFE FINANCIAL CORPORATION	+9.94%	42.08B	B+
PRUDENTIAL FINANCIAL, INC.	+6.55%	39.7B	B+
GENERALI	+19.86%	38.01B	B
SUN LIFE FINANCIAL INC.	+2.31%	29.79B	B
GREAT-WEST LIFECO INC.	-7.25%	27.63B	B-
PRUDENTIAL PLC	-20.13%	24.06B	A-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes